Zero CAC? LDL Cholesterol May Not Predict MI, ASCVD | tctmd.com tctmd.com/news/zero-cac-…

#ICYMI: LDL, coronary plaque and risk for ASCVD Martin Bødtker Mortensen @JacobBentzon Ron Blankstein Michael J. Blaha Khurram Nasir @dzayeo Michael Maeng #AHAJournals

The Advanced Clinical Session on "Lipid management throughout a lifetime" has just started at the 📍Anitschkow Hall. #EASCongress2023

Excellent discussions on the use of imaging for personalized prevention! I agree with most points, but I consider biomarkers and imaging as complementary tools, not mutually exclusive. Lale Tokgozoglu Steve Nicholls academic.oup.com/eurheartj/arti…

I am standing for President-Elect of the European Atherosclerosis Society (EAS). Please vote before June 30! Link: eas-society.org/wp-login.php European Atherosclerosis Society

1/2 🧵 👉Another attempt to discuss the role of the LDLc in Atherosclerosis referring to “LDL-paradox” doi.org/10.1111/joim.1… ☝️Please, read the fantastic editorial by Borge G Nordestgaard et al, explaining the real reasons of the findings in the manuscript doi.org/10.1111/joim.1…

"Serial troponin-I and long-term outcomes in subjects with suspected acute coronary syndrome" finally out in #EJPC European Society of Cardiology Journals Link to full paper: academic.oup.com/eurjpc/advance… Muthu Vaduganathan Dr. Deepak L. Bhatt Tor Biering-Sørensen, MD, MSc, MPH, PhD @CIRL_DK Graphical abstract below:

Martin Bødtker Mortensen 2 critical points? #1 Are these results generalizable? Yes, seen same in MESA over long term period of 16+ years #2 Implications? #SeeDiseaseTreatDisease #NotAllLdlCreatedEqual

Hot of the press! jacc.org/doi/10.1016/j.… 🔥Very important paper >autoimmunity & athero: tour de force w/ CCTA and CAC severity/plaque burden led by Martin Bødtker Mortensen and others. Awareness is KEY & need for ongoing mechanistic work in #cardiorheum.

"TO ARMS - TO ARMS" -- CITIZENS AND CLINICIANS OF THE WORLD - Beg borrow or steal to get this incredible new data from 100,000 people in the Copenhagen Study - The last 25 years of my teachings have been vindicated 😆. It is apoB alone - not LDL-C and for sure, not as so many

This is a VERY important finding in my opinion. The days of only monitoring ‘LDL’ (bad) cholesterol should be OVER. ApoB is MUCH MORE IMPORTANT. Everyone should be tracking their ApoB levels as well as the rest of their lipid panel.